Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.610
-0.390 (-7.80%)
At close: Sep 12, 2025, 4:00 PM EDT
4.640
+0.030 (0.65%)
After-hours: Sep 12, 2025, 5:39 PM EDT

Precision BioSciences Stock Forecast

DTIL's stock price has decreased by -56.1% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Precision BioSciences stock have a consensus rating of "Strong Buy" and an average price target of $47, which forecasts a 919.52% increase in the stock price over the next year. The lowest target is $34 and the highest is $60.

Price Target: $47 (+919.52%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$34$47$60$60
Change+637.53%+919.52%+1201.5%+1201.5%
* Price targets were last updated on May 21, 2025.

Analyst Ratings

The average analyst rating for Precision BioSciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy211111
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total322222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$60
Strong BuyReiterates$60+1,201.52%May 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$60
Strong BuyReiterates$60+1,201.52%Mar 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$60
Strong BuyReiterates$60+1,201.52%Mar 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$60
Strong BuyReiterates$60+1,201.52%Feb 19, 2025
BMO Capital
BMO Capital
Buy
Upgrades
$34
BuyUpgrades$34+637.53%Jan 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
11.02M
from 68.70M
Decreased by -83.96%
Revenue Next Year
25.91M
from 11.02M
Increased by 135.19%
EPS This Year
-5.29
from 1.04
EPS Next Year
-2.00
from -5.29
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
24.29M115.53M25.10M48.73M68.70M11.02M25.91M
Revenue Growth
9.21%375.72%-78.28%94.15%40.98%-83.96%135.19%
EPS
-62.85-15.64-38.10-15.961.04-5.29-2.00
EPS Growth
-------
Forward PE
-------
No. Analysts
-----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High23.2M69.7M
Avg11.0M25.9M
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
-66.2%
532.9%
Avg
-84.0%
135.2%
Low--

EPS Forecast

EPS2025202620272028
High-2.910.06
Avg-5.29-2.00
Low-7.74-4.93

EPS Growth

EPS Growth2025202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.